Collagen vascular disease in the lungs

More documents

Recommendations

Info

Therapy Empiric 1) ALP: Pulse medrol x 3 days ± cyclophosphamide 2) DAH: Pulse medrol x 3 d ± cyclophosphamide ± plasmaphoresis 3) CIIP: Prednisone ± azathiopr<strong>in</strong>e or cyclophosphamide Antoniou et al. ERJ 2009; 33: 882-96
Pulmonary Approach to CVD Patients Kim et al. Chest 2009; 136: 1397-1405
Page 1 and 2: COLLAGEN VASCULAR DISEASE IN THE LU
Page 3 and 4: Forms of Lung Disease in CVD • In
Page 5 and 6: ILD IN COLLAGEN VASCULAR DISEASE (C
Page 7 and 8: Antoniou et al. ERJ 2009; 33: 882-9
Page 9 and 10: NSIP: CXR • Bilateral • Fine re
Page 11 and 12: HRCT: UIP vs. NSIP
Page 13 and 14: Mean survivals of patients: HRCT di
Page 15 and 16: Background ILD common in SSc: 75% (
Page 17 and 18: CXR Limited value Imaging HRCT Very
Page 19 and 20: Serial PFTs & Prognosis: IPF Bad Pr
Page 21 and 22: Prognostic Algorithm Used 215 SSc-I
Page 23 and 24: 6MWT & Prognosis: IPF • Safe •
Page 25 and 26: SSc: Exercise Testing CPEX has been
Page 27 and 28: Therapy 1) Prednisone ?? renal cris
Page 29 and 30: RHEUMATOID ARTHRITIS (RA)
Page 31 and 32: RA-ILD worse prognosis than other C
Page 33 and 34: PFTs Good at picking up lung diseas
Page 35 and 36: Therapy No randomised controlled tr
Page 37 and 38: ILD uncommon in SLE: Background •
Page 39: Lung Biopsy Not often done CIP: NSI

Collagen vascular disease in the lungs

Create successful ePaper yourself

Delete template?

Save as template?